Stay updated on XMT-1660 in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XMT-1660 in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial record for Emi-Le in participants with solid tumors is now displayed, including study design, eligibility requirements, contact information, and recruiting locations. The record also outlines the trial’s safety and efficacy measures.
    Difference
    85%
    Check dated 2026-11-11T01:07:33.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:19:24.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    An NIH-wide notice was added about the transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:51:33.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-13T22:49:17.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-06T23:10:21.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the expected study record content. This indicates restricted access rather than updated study details.
    Difference
    21%
    Check dated 2026-09-22T23:55:08.000Z thumbnail image

Stay in the know with updates to XMT-1660 in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.